IMPROVE observational program: safety and effectiveness of biphasic insulin aspart 30 in routine clinical practice. Overview of starting characteristics of the Russian patient cohort
AIM: To analyse starting characteristics of the Russian patient cohort included in the IMPROVE observational program with reference to its demographiccomposition and clinical features of the disease in patients allocated to different groups depending on previous treatment, reason for prescribing DiA...
Main Authors: | Marina Vladimirovna Shestakova, Akill Ballan |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2009-12-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/5713 |
Similar Items
-
Therapy with biphasic insulin aspart 30/70 (NovoMix 30) improves glycemic control in patients with type 2 diabetes mellitus: resultsfrom a Russian cohort of IMPROVE observational program designed to study safety and efficiency of biphasic insulin aspart 30 inroutine clinical practice
by: Marina Vladimirovna Shestakova, et al.
Published: (2010-03-01) -
Insulin therapy and body weight: benefits of biphasic human insulin analogue NovoMix 30
by: Elena Viktorovna Surkova
Published: (2013-03-01) -
Cost-effectiveness of insulin degludec/insulin aspart versus biphasic insulin aspart in Chinese population with type 2 diabetes
by: Qiong Luo, et al.
Published: (2022-10-01) -
Dvukhfaznyy insulin aspart 30 plyusmetformin: effektivnaya kombinatsiyadlya lecheniya sakharnogo diabeta 2 tipa
by: M Kvapil, et al.
Published: (2006-06-01) -
Effektivnost' i bezopasnost' dvukhfaznogo insulina Aspart 30 po dannym lecheniya patsientov s sakharnym diabetom 2 tipa v Rossiyskoy Federatsii: rezul'taty mnogotsentrovogo nablyudatel'nogo issledovaniya
by: Marina Vladimirovna Shestakova, et al.
Published: (2007-09-01)